The pathogenesis of hyperacute xenograft rejection.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  American Journal of Kidney Diseases

• Publication date

  1992-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0272-6386(12)70310-4PMID 1415213
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• William Henry Howell and Jay McLean: The Experimental Context for the Discovery of Heparin

  2015cited by this paper
• EVIDENCE THAT POLYREACTIVE ANTIBODIES ARE DEPOSITED IN REJECTED DISCORDANT XENOGRAFTS

  1993cited by this paper
• Administration of nonanticoagulant heparin inhibits the loss of glycosaminoglycans from xenogeneic cardiac grafts and prolongs graft survival.

  1993cited by this paper
• Evidence that 15-deoxyspergualin inhibits natural antibody production but fails to prevent hyperacute rejection in a discordant xenograft model.

  1992cited by this paper
• Mechanism of complement activation in the hyperacute rejection of porcine organs transplanted into primate recipients.

  1992cited by this paper
• Cardiac xenografting in the pig-to-rhesus monkey model: manipulation of antiendothelial antibody prolongs survival.

  1992cited by this paper
• Identification of carbohydrate structures that bind human antiporcine antibodies: implications for discordant xenografting in humans.

  1992cited by this paper
• Effect of soluble complement receptor type 1 on natural antibody levels during xenograft rejection.

  1992cited by this paper
• Cellular early immune recognition of xenogeneic vascular endothelium.

  1992cited by this paper
• Xenotransplantation — A Brief History of Clinical Experiences: 1900–1965

  1991cited by this paper
• The barrier to xenotransplantation.

  1991cited by this paper
• Neutrophil adhesion to xenogeneic endothelium via iC3b.

  1991cited by this paper
• THE EFFECT OF SOLUBLE COMPLEMENT RECEPTOR TYPE 1 ON HYPERACUTE XENOGRAFT REJECTION

  1991cited by this paper
• THE ROLE OF NATURAL ANTIBODIES IN THE ACTIVATION OF XENOGENIC ENDOTHELIAL CELLS

  1991cited by this paper
• POLYREACTIVITY AND ANTIGEN SPECIFICITY OF HUMAN XENOREACTIVE MONOCLONAL AND SERUM NATURAL ANTIBODIES

  1991cited by this paper
• Inhibition of complement-mediated endothelial cell cytotoxicity by decay-accelerating factor. Potential for prevention of xenograft hyperacute rejection.

  1991cited by this paper
• Prolonged survival of a discordant cardiac xenograft in a rhesus monkey.

  1991cited by this paper
• Immunopathology of hyperacute xenograft rejection in a swine-to-primate model.

  1991cited by this paper
• Histopathology of hyperacute rejection of the heart: experimental and clinical observations in allografts and xenografts.

  1991cited by this paper
• Hyperacute rejection of xenografts in the complete absence of antibody.

  1991cited by this paper
• Natural autoantibodies: from 'horror autotoxicus' to 'gnothi seauton'.

  1991cited by this paper
• The role of C5a and antibody in the release of heparan sulfate from endothelial cells

  1991cited by this paper
• Experience with Clinical Kidney Xenotransplantation

  1991cited by this paper
• Accommodation — The Role of Natural Antibody and Complement in Discordant Xenograft Rejection

  1991cited by this paper
• Endothelial cell antigens recognized by xenoreactive human natural antibodies.

  1990cited by this paper
• An ELISA assay for xenoreactive natural antibodies.

  1990cited by this paper
• Transplantation of discordant xenografts: a review of progress.

  1990cited by this paper
• Humoral immune reactions to pig antigens in humans.

  1990cited by this paper
• Reconsideration of the mechanism of first-set vascularized allograft rejection: some concluding remarks.

  1990cited by this paper
• An Elsia Assay For Xenoreactive Natural Antiboides

  1990cited by this paper
• Complement proteins C5b-9 induce vesiculation of the endothelial plasma membrane and expose catalytic surface for assembly of the prothrombinase enzyme complex.

  1990cited by this paper
• Prolongation of survival of discordant kidney xenografts by C6 deficiency.

  1990cited by this paper
• Release of heparan sulfate from endothelial cells. Implications for pathogenesis of hyperacute rejection

  1990cited by this paper
• Probing the human B-cell repertoire with EBV: polyreactive antibodies and CD5+ B lymphocytes.

  1989cited by this paper
• Preformed natural antibodies (PNAB) and possibilities of modulation of hyperacute xenogeneic rejection (HXAR).

  1989cited by this paper
• Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects.

  1989cited by this paper
• Endothelial Activation and Inflammation

  1989cited by this paper
• Mediator‐induced activation of xanthine oxidase in endothelial cells

  1989cited by this paper
• Removal of anti-HLA antibodies by extracorporeal immunoadsorption to enable renal transplantation.

  1989cited by this paper
• Tumor necrosis factor/cachectin increases permeability of endothelial cell monolayers by a mechanism involving regulatory G proteins

  1989cited by this paper
• CD5+ B lymphocytes, polyreactive antibodies and the human B-cell repertoire.

  1989cited by this paper
• Xenogeneic transplantation. A review.

  1988cited by this paper
• THE MECHANISM OF DISCORDANT XENOGRAFT REJECTION

  1988cited by this paper
• Plasma clearance of human extracellular-superoxide dismutase C in rabbits.

  1988cited by this paper
• Cytokine activation of vascular endothelium. Effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor.

  1988cited by this paper
• Cytotoxic action and other metabolic consequences of terminal complement proteins.

  1988cited by this paper
• DISCORDANT HEART XENOGRAFTS IN THE RAT: Additional Effect of Plasma Exchange and Cyclosporine, Cyclophosphamide, or Splenectomy in Delaying Hyperacute Rejection

  1988cited by this paper
• Cytotoxic Action and Other Metabolic Consequences of Terminal Complement Proteins

  1988cited by this paper
• Renal xenograft rejection: prolonging effect of captopril, ACE-inhibitors, prostacyclin, and cobra venom factor.

  1987cited by this paper
• Experiences with known ABO-mismatched renal transplants.

  1987cited by this paper
• Present experiences in a series of 26 ABO-incompatible living donor renal allografts.

  1987cited by this paper
• Identification of an inducible endothelial-leukocyte adhesion molecule.

  1987cited by this paper
• Heparin-induced release of extracellular superoxide dismutase to human blood plasma.

  1987cited by this paper
• Heparan Sulfate Species and Blood Vessel Wall Function

  1987cited by this paper
• Isohemagglutinins and preformed natural antibodies in xenogeneic organ transplantation.

  1987cited by this paper
• The endothelial surface and responses to injury.

  1986cited by this paper
• Cloned bovine aortic endothelial cells synthesize anticoagulantly active heparan sulfate proteoglycan.

  1986cited by this paper
• The endothelial surface and responses to injury.

  1986cited by this paper
• Hyperacute rejection in a discordant (pig to baboon) cardiac xenograft model.

  1986cited by this paper
• Induction and detection of a human endothelial activation antigen in vivo

  1986cited by this paper
• Complement in the pathophysiology and diagnosis of human diseases.

  1986cited by this paper
• Modulation of endothelial cell hemostatic properties by tumor necrosis factor

  1986cited by this paper
• Degradation of heparan sulfate in the subendothelial extracellular matrix by a readily released heparanase from human neutrophils. Possible role in invasion through basement membranes.

  1985cited by this paper
• Naturally occurring antibodies against nine common antigens in human sera. I. Detection, isolation and characterization.

  1982cited by this paper
• Sensitivity of long-standing xenografts of rat hearts to humoral antibodies.

  1979cited by this paper
• Delayed rejection of cardiac xenografts in C6-deficient rabbits.

  1979cited by this paper
• Hyperacute renal allograft rejection in the primate. Therapeutic limitations of antiplatelet agents alone and combined with heparin.

  1976cited by this paper
• A primate model of hyperacute renal allograft rejection.

  1975cited by this paper
• Antibodies reactive with cell surface carbohydrates.

  1975cited by this paper
• A controlled sequential morphologic study of hyperacute cardiac allograft rejection in the rat.

  1975cited by this paper
• Morphologic study of the participation of the complement system in hyperacute rejection of renal xenotransplants.

  1972cited by this paper
• Renal heterotransplant rejection. A model for separation of humoral and cellular mechanisms.

  1971cited by this paper
• Renal heterotransplant rejection. A model for separation of humoral and cellular mechanisms.

  1971cited by this paper
• Mechanism and modification of rejection of heterografts between divergent species.

  1970cited by this paper
• Renal xenograft prolongation by suppression of natural antibody.

  1968cited by this paper
• EFFECT OF COBRA VENOM-INDUCED INHIBITION OF COMPLEMENT ACTIVITY ON ALLOGRAFT AND XENOGRAFT REJECTION REACTIONS1

  1967cited by this paper
• EXPERIMENTAL RENAL HETEROTRANSPLANTATION III. PASSIVE TRANSFER OF TRANSPLANTATION IMMUNITY

  1967cited by this paper
• Natural antibodies and the immune response.

  1966cited by this paper
• EXPERIMENTAL RENAL HETEROTRANSPLANTATION: I. In Widely Divergent Species

  1966cited by this paper
• RENAL HETEROTRANSPLANTATION IN MAN.

  1964cited by this paper
• RENAL HETEROTRANSPLANTATION FROM BABOON TO MAN: EXPERIENCE WITH 6 CASES

  1964cited by this paper

• Complement, Coagulation, and Fibrinolysis: The Role of the Endothelium and Its Glycocalyx Layer in Xenotransplantation

  2024cites this paper
• Research progress on CD8 + T cell immune regulation in allogenic transplantation.

  2023cites this paper
• Accommodation in allogeneic and xenogeneic organ transplantation: Prevalence, impact, and implications for monitoring and for therapeutics.

  2022cites this paper
• Three-dimensional decellularized tumor extracellular matrices with different stiffness as bioengineered tumor scaffolds

  2021cites this paper
• Strategies based on organ decellularization and recellularization

  2019cites this paper
• Immunological challenges and therapies in xenotransplantation.

  2014cites this paper
• A Randomized 2×2 Factorial Trial, Part 1: Single-Dose Rabbit Antithymocyte Globulin Induction May Improve Renal Transplantation Outcomes

  2014cites this paper
• Induction of Human Blood Group A Antigen Expression on Mouse Cells, Using Lentiviral Gene Transduction

  2010cites this paper
• Evaluation of Immunosuppressive Regimens in ABO‐Incompatible Living Kidney Transplantation—Single Center Analysis

  2007cites this paper
• Depletion of Pulmonary Intravascular Macrophages Prevents Hyperacute Pulmonary Xenograft Dysfunction

  2006cites this paper
• B-cell tolerance following ABO-incompatible infant heart transplantation.

  2006influential citation
• [Acute cell rejection in ex vivo model of swine-human renal xenotransplantation].

  2004cites this paper
• Rechazo celular agudo en modelo ex vivo de xenotrasplante renal cerdo-hombre

  2004cites this paper
• Ovarian tissue xenografting.

  2003cites this paper
• Prospects for the temporary treatment of acute liver failure.

  2002cites this paper
• Complement Regulation and the Host Response to Infection

  2001cites this paper
• Xenogeneic liver support systems

  2001cites this paper
• Xeno Assistance of the Faling Liver

  2001cites this paper
• CONTRIBUTION OF ENDOGENOUS PIG COMPLEMENT REGULATORY MOLECULES

  2000cites this paper
• Prolongation of rat islet xenograft survival in the liver of IFN-gamma-deficient mice.

  2000cites this paper
• Extracorporeal perfusion for the treatment of acute liver failure.

  2000cites this paper
• Porcine endogenous retroviruses inhibit human immune cell function: risk for xenotransplantation?

  2000cites this paper
• Prolongation of Rat Islet Xenograft Survival in the Liver of IFN-γ-Deficient Mice

  2000cites this paper
• MOLECULAR CLONING AND CHARACTERIZATION OF THE PIG HOMOLOGUE TO HUMAN CD29, THE INTEGRIN b1 SUBUNIT

  2000cites this paper
• Induction of T-independent xenotolerance in a semi-discordant hamster-to-presensitized, nude rat model.

  1999cites this paper
• Immunoisolation of Hybrid Liver Support Systems by Semipermeable Membranes

  1997cites this paper
• Treatment of rat hemiparkinson model with xenogeneic neural transplantation: Tolerance induction by anti‐T‐cell antibodies

  1997cites this paper
• Consideration of Potential Immunological Problems in the Application of Xenogenic Hybrid Liver Support

  1996cites this paper
• Efficacy of leflunomide to reduce xenoantibody titers in vivo: an evaluation of the prolongation of discordant xenograft survival.

  1996cites this paper
• Improved experimental cardiac xenograft survival with cyclophosphamide and intrathymic donor cells

  1996cites this paper
• Xenotransplantation: Lessons from nature

  1996cites this paper
• Long-term results with single pediatric donor kidney transplants in adult recipients.

  1996cites this paper
• Identification of porcine membrane antigens involved in the cytotoxic response mediated by human xenoreactive antibodies

  1996cites this paper
• Manipulation of xenogeneic skin and/or renal graft survival in the rat-mouse concordant combination by portal vein pretransplant transfusion.

  1995cites this paper
• Long-Term Viability of Isolated Bovine Adrenal Medullary Chromaffin Cells following Intrastriatal Transplantation

  1995cites this paper
• Long-term viability of isolated bovine adrenal medullary chromaffin cells following intrastriatal transplantation.

  1995cites this paper
• A Perspective on Xenograft Rejection and Accommodation 1

  1994cites this paper
• MECHANISMS OF INJURY IN PORCINE LIVERS PERFUSED WITH BLOOD OF PATIENTS WITH FULMINANT HEPATIC FAILURE

  1994cites this paper
• Xenografts: do they have a role?

  1994cites this paper
• 5 Xenografts: do they have a role?

  1994cites this paper
• A perspective on xenograft rejection and accommodation.

  1994cites this paper
• Porcine endothelial cell antigens recognized by human natural antibodies.

  1994cites this paper
• Porcine platelet antigens recognized by human xenoreactive natural antibodies.

  1994cites this paper
• Basic and clinical considerations in the use of xenografts.

  1994cites this paper